Home › Funds › DEERFIELD MANAGEMENT COMPANY, L.P. › MNPR
DEERFIELD MANAGEMENT COMPANY, L.P. position in MNPR
MONOPAR THERAPEUTICS INC · Health Care
DEERFIELD MANAGEMENT COMPANY, L.P. reported holding 323,745 shares of MNPR (MONOPAR THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$30.0M, representing 0.38% of its reported portfolio and ranking #49 among its reported holdings. DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed MNPR holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DEERFIELD MANAGEMENT COMPANY, L.P.'s MNPR position evolved
DEERFIELD MANAGEMENT COMPANY, L.P. first disclosed a stake in MNPR in Q3 2025 at 159,765 shares (US$13.0M). The position peaked in Q2 2026 at 323,745 shares, worth US$30.0M. Across 4 filings, DEERFIELD MANAGEMENT COMPANY, L.P. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 323,745 shares valued at US$30.0M. Notable position changes include a 90% increase in Q1 2026 (shares rose 69% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 159.76K | $13.05M | New |
| Q4 2025 | 170.56K | $11.14M | Add |
| Q1 2026 | 323.75K | $17.74M | Add |
| Q2 2026 | 323.75K | $29.98M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MNPR and 13F data
MNPR (MONOPAR THERAPEUTICS INC) is a Health Care company. 84 other funds we track also report a position in MNPR — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$61.8M), Saturn V Capital Management LP (US$28.9M), Siren, L.L.C. (US$25.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MNPR
- RA CAPITAL MANAGEMENT, L.P. 667.21K sh · $61.78M · Q2 2026
- Saturn V Capital Management LP 311.98K sh · $28.89M · Q2 2026
- Siren, L.L.C. 270.12K sh · $25.01M · Q2 2026
- ADAR1 Capital Management, LLC 217.59K sh · $20.15M · Q2 2026
- TCG Crossover Management, LLC 203.33K sh · $18.83M · Q2 2026
- Vivo Capital, LLC 90.50K sh · $8.38M · Q2 2026
- Ikarian Capital, LLC 47.86K sh · $4.43M · Q2 2026
- STEMPOINT CAPITAL LP 30.12K sh · $2.79M · Q2 2026
- Ishara Investments LP 12.30K sh · $1.14M · Q2 2026
- Martin Investment Management, LLC 2.33K sh · $215.46K · Q2 2026
More on DEERFIELD MANAGEMENT COMPANY, L.P.
FAQ
How long has DEERFIELD MANAGEMENT COMPANY, L.P. held MNPR?
DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed MNPR holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in MNPR?
As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 323.75K shares of MNPR (MONOPAR THERAPEUTICS INC), valued at $29.98M, representing 0.38% of its reported portfolio and ranking #49.
Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling MNPR?
In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. held unchanged its position in MNPR. The position peaked in Q2 2026 at 323.75K shares.
Which other funds hold MNPR?
Other major institutional holders of MNPR include RA CAPITAL MANAGEMENT, L.P., Saturn V Capital Management LP, Siren, L.L.C., among 84 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.